NO973753L - Helicobacter pylori antigen - Google Patents

Helicobacter pylori antigen

Info

Publication number
NO973753L
NO973753L NO973753A NO973753A NO973753L NO 973753 L NO973753 L NO 973753L NO 973753 A NO973753 A NO 973753A NO 973753 A NO973753 A NO 973753A NO 973753 L NO973753 L NO 973753L
Authority
NO
Norway
Prior art keywords
antigen
helicobacter pylori
pylori antigen
addition
fragments
Prior art date
Application number
NO973753A
Other languages
English (en)
Other versions
NO973753D0 (no
Inventor
Christopher John Smith
Robert Llewellyn Clancy
Allan Cripps
Original Assignee
Cortecs Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cortecs Ltd filed Critical Cortecs Ltd
Publication of NO973753D0 publication Critical patent/NO973753D0/no
Publication of NO973753L publication Critical patent/NO973753L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K2039/106—Vibrio; Campylobacter; Not used, see subgroups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Nytt H. pylori-antigen. An- vendelse av dette ved diagnostisering av H. pylori-infeksjon er også bes- krevet, deriblant fremgangsmåter for nevnte diagnostisering og flere sett for anvendelse ved en slik fremgangs- måte. Dessuten er nye antigenfragmenter til antigenet tilveiebragt i tillegg til vaksiner omfattende enten antigenet eller én eller flere antigenfragmenter.
NO973753A 1995-02-15 1997-08-14 Helicobacter pylori antigen NO973753L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9502899.9A GB9502899D0 (en) 1995-02-15 1995-02-15 Novel antigen
PCT/GB1996/000351 WO1996025430A1 (en) 1995-02-15 1996-02-15 Helicobacter pylori antigen

Publications (2)

Publication Number Publication Date
NO973753D0 NO973753D0 (no) 1997-08-14
NO973753L true NO973753L (no) 1997-08-14

Family

ID=10769595

Family Applications (1)

Application Number Title Priority Date Filing Date
NO973753A NO973753L (no) 1995-02-15 1997-08-14 Helicobacter pylori antigen

Country Status (17)

Country Link
EP (1) EP0809653B1 (no)
JP (1) JPH11503999A (no)
KR (1) KR19980701698A (no)
CN (1) CN1175955A (no)
AT (1) ATE206138T1 (no)
AU (1) AU714222B2 (no)
CA (1) CA2212952A1 (no)
DE (1) DE69615537T2 (no)
DK (1) DK0809653T3 (no)
ES (1) ES2164231T3 (no)
FI (1) FI973335A (no)
GB (1) GB9502899D0 (no)
IL (1) IL117151A (no)
NO (1) NO973753L (no)
NZ (1) NZ301334A (no)
PT (1) PT809653E (no)
WO (1) WO1996025430A1 (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6599509B2 (en) * 1997-09-02 2003-07-29 Massachusetts Institute Of Technology Compositions and methods comprising helicobacter antigens for treatment and prevention of inflammatory bowel disease
CN1105185C (zh) * 1998-11-30 2003-04-09 上海晶莹生物技术有限公司 基因表达幽门螺杆菌细胞毒素相关基因a蛋白抗原制备工艺
AUPQ854100A0 (en) * 2000-07-03 2000-07-27 Helirad Pty Ltd Methods for monitoring treatment of helicobacter infection
SE0101030D0 (sv) * 2001-03-23 2001-03-23 Nordic Bio Ab Immunogenic cell surface proteins of helicobacter pylori

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5459041A (en) * 1988-02-18 1995-10-17 Enteric Research Laboratories, Inc. Campylobacter pylori antigens and uses thereof for detection of Campylobacter pylori infection
DE4139840B4 (de) * 1990-12-04 2005-06-02 Quidel Corp., San Diego Antigen-Zubereitung zum Nachweis von H. pylori
PL172125B1 (pl) * 1992-04-29 1997-08-29 Auspharm Int Ltd Sposób wykrywania trwajacych infekcji Helicobacter pyroli w komórkach ssaków PL PL PL

Also Published As

Publication number Publication date
KR19980701698A (ko) 1998-06-25
IL117151A0 (en) 1996-06-18
ATE206138T1 (de) 2001-10-15
NO973753D0 (no) 1997-08-14
EP0809653B1 (en) 2001-09-26
NZ301334A (en) 1999-08-30
GB9502899D0 (en) 1995-04-05
AU4672896A (en) 1996-09-04
ES2164231T3 (es) 2002-02-16
WO1996025430A1 (en) 1996-08-22
IL117151A (en) 2001-06-14
DE69615537D1 (en) 2001-10-31
JPH11503999A (ja) 1999-04-06
FI973335A0 (fi) 1997-08-14
CA2212952A1 (en) 1996-08-22
CN1175955A (zh) 1998-03-11
AU714222B2 (en) 1999-12-23
EP0809653A1 (en) 1997-12-03
MX9706267A (es) 1997-11-29
DE69615537T2 (de) 2002-04-18
FI973335A (fi) 1997-08-14
PT809653E (pt) 2002-03-28
DK0809653T3 (da) 2001-11-19

Similar Documents

Publication Publication Date Title
NO963508L (no) Urease-basert vaksine og behandling av Helicobacter-infeksjon
NO980883D0 (no) Forbindelser og fremgangsmåter for immunterapi og diagnose av tuberkulose
IT7928146A0 (it) Procedimento per cementare pozzi, e cementi gasati utili in tale procedimento.
DE69333110D1 (de) Mit dem cytotoxin von helicobacter pylori assoziiertes, immunodominantes antigen verwendbar in impfstoffen und zur diagnose
GB2303854B (en) Helicobacter proteins and vaccines
NO874191D0 (no) Fremgangsmaate og apparat til undersoekelse av drag og moment-tap ved en boreoperasjon.
NO893769D0 (no) Fremgangsmaate for behandling av naturgass.
NO991694L (no) Forbindelser og metoder for immunoterapi og diagnose av tuberkulose
NO905133L (no) Polymerisasjonsprosess, fremgangsmaate til styring av prosessen og apparat til utfoerelse av fremgangsmaaten.
NO903933D0 (no) Geonett, fremgangsmaate til fremstilling av dette og fremgangsmaate for jordarmering ved bruk av geonett.
WO1997008318A3 (en) Compounds and methods for treatment and diagnosis of prostate cancer
NO864241D0 (no) Fremgangsmaate ved bleking av cellulosemasse eller fraksjon derav, anlegg til bruk ved gjennomfoeringen av fremgangsmaaten og skruepresse, saerlig til bruk ved fremgangsmaaten henholdsvis i anlegget.
HK1005541A1 (en) Treatment of helicobacter associated gastroduodenal disease
DK656687D0 (da) Bakterielle antigener, antistoffer, vacciner og fremgangsmaade til fremstilling deraf
NO900309L (no) Benzocykloalkenyldihydroksyalkansyrederivater, og fremgangsmaate til fremstilling derav.
HK1004677A1 (en) Antigenic preparation for treatment or prevention of helicobacter infection
NO903757D0 (no) Chitin.chitosan-oligomer med 2,5-anhydromannitol endegruppe eller 2,5-anhydromannose endegruppe og fremgangsmaate til fremstilling derav.
NO954318D0 (no) Immunogent preparat av OspC-antigenvaksiner for forhindring og behandling av Lymesykdom, samt rekombinante fremgangsmåter for fremstilling av slike antigener
NO872776D0 (no) Transduseranordning for trykkboelger, og fremgangsmaate for fremstilling av slik transduseranordning.
NO973753L (no) Helicobacter pylori antigen
DK315387D0 (da) Androst-4-en-3,17-dioner og fremgangsmaade til fremstilling deraf
IT8121484A0 (it) Estratto da piante del genere epimedium, procedimento per lapreparazione di detto estratto, agente immunostimolante che comprende detto estratto come componente efficace e immunoterapia mediante l'impiego di detto estratto.
FR2580176B1 (fr) Vaccin antirabique avirulent
NO884654D0 (no) Virusantigen, fremgangsmaate for dets fremstilling og anvendelse i diagnose og terapi (vaksine).
NO874726D0 (no) Mappe eller lignende, framgangsmaate og apparat for framstilling av samme.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application